Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard Zigeuner

Showing results (31-40 of 166) with videos related to

Pageof 17
Sort By:
Histopathology|September 11, 2012
Presence and extent of histological tumour necrosis is an adverse prognostic factor in papillary type 1 but not in papillary type 2 renal cell carcinomaMartin Pichler, Georg C Hutterer, Thomas F Chromecki, et al.
European Urology|January 29, 2011
European guidelines for the diagnosis and management of upper urinary tract urothelial cell carcinomas: 2011 updateMorgan Rouprêt, Richard Zigeuner, Juan Palou, et al.
Urology|August 30, 2003
Do patients with a higher body mass index have a greater risk of advanced-stage renal cell carcinoma?Luigi Schips, Richard Zigeuner, Katja Lipsky, et al.
Urology|November 20, 2003
Detection of prostate cancer by TURP or open surgery in patients with previously negative transrectal prostate biopsiesRichard Zigeuner, Luigi Schips, Katja Lipsky, et al.
European Urology|July 18, 2006
Serum levels of vascular endothelial growth factor (VEGF) and endostatin in renal cell carcinoma patients compared to a control groupLuigi Schips, Orietta Dalpiaz, Katja Lipsky, et al.
Journal of Surgical Oncology|October 23, 2004
Does overweight impact on the prognosis of patients with renal cell carcinoma? A single center experience of 683 patientsLuigi Schips, Katja Lipsky, Richard Zigeuner, et al.
Virchows Archiv : an International Journal of Pathology|November 30, 2005
Alpha-methylacyl-CoA racemase (AMACR/P504S) protein expression in urothelial carcinoma of the upper urinary tract correlates with tumour progressionCord Langner, Gerhild Rupar, Sebastian Leibl, et al.
Urologic Oncology|July 17, 2014
Low preoperative lymphocyte-monocyte ratio (LMR) represents a potentially poor prognostic factor in nonmetastatic clear cell renal cell carcinomaGeorg C Hutterer, Caroline Stoeckigt, Tatjana Stojakovic, et al.
The Journal of Urology|January 28, 2015
The Preoperative AST/ALT (De Ritis) Ratio Represents a Poor Prognostic Factor in a Cohort of Patients with Nonmetastatic Renal Cell CarcinomaAngelika Bezan, Edvin Mrsic, Daniel Krieger, et al.
European Urology|December 9, 2008
External validation of the Mayo Clinic stage, size, grade, and necrosis (SSIGN) score for clear-cell renal cell carcinoma in a single European centre applying routine pathologyRichard Zigeuner, Georg Hutterer, Thomas Chromecki, et al.
Pageof 17

Showing results (31-40 of 166) with videos related to

Sort By:
Pageof 17
Histopathology|September 11, 2012
Presence and extent of histological tumour necrosis is an adverse prognostic factor in papillary type 1 but not in papillary type 2 renal cell carcinomaMartin Pichler, Georg C Hutterer, Thomas F Chromecki, et al.
European Urology|January 29, 2011
European guidelines for the diagnosis and management of upper urinary tract urothelial cell carcinomas: 2011 updateMorgan Rouprêt, Richard Zigeuner, Juan Palou, et al.
Urology|August 30, 2003
Do patients with a higher body mass index have a greater risk of advanced-stage renal cell carcinoma?Luigi Schips, Richard Zigeuner, Katja Lipsky, et al.
Urology|November 20, 2003
Detection of prostate cancer by TURP or open surgery in patients with previously negative transrectal prostate biopsiesRichard Zigeuner, Luigi Schips, Katja Lipsky, et al.
European Urology|July 18, 2006
Serum levels of vascular endothelial growth factor (VEGF) and endostatin in renal cell carcinoma patients compared to a control groupLuigi Schips, Orietta Dalpiaz, Katja Lipsky, et al.
Journal of Surgical Oncology|October 23, 2004
Does overweight impact on the prognosis of patients with renal cell carcinoma? A single center experience of 683 patientsLuigi Schips, Katja Lipsky, Richard Zigeuner, et al.
Virchows Archiv : an International Journal of Pathology|November 30, 2005
Alpha-methylacyl-CoA racemase (AMACR/P504S) protein expression in urothelial carcinoma of the upper urinary tract correlates with tumour progressionCord Langner, Gerhild Rupar, Sebastian Leibl, et al.
Urologic Oncology|July 17, 2014
Low preoperative lymphocyte-monocyte ratio (LMR) represents a potentially poor prognostic factor in nonmetastatic clear cell renal cell carcinomaGeorg C Hutterer, Caroline Stoeckigt, Tatjana Stojakovic, et al.
The Journal of Urology|January 28, 2015
The Preoperative AST/ALT (De Ritis) Ratio Represents a Poor Prognostic Factor in a Cohort of Patients with Nonmetastatic Renal Cell CarcinomaAngelika Bezan, Edvin Mrsic, Daniel Krieger, et al.
European Urology|December 9, 2008
External validation of the Mayo Clinic stage, size, grade, and necrosis (SSIGN) score for clear-cell renal cell carcinoma in a single European centre applying routine pathologyRichard Zigeuner, Georg Hutterer, Thomas Chromecki, et al.
Pageof 17